We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Chicken Antibodies Guide Cancer-Killing Nanotubes

By LabMedica International staff writers
Posted on 18 Dec 2009
A recent paper described a novel hi-tech mechanism for tracking and destroying cancer cells. More...
The method is based on a highly specific chicken antibody (immunoglobulin Y, or IgY) directed at the cancer cell surface HER2 (human epidermal growth factor receptor 2) protein covalently bound to single-walled nanotubes.

The nanotubes (SWNTs) exhibit two unique optical properties that make them useful for this application. When exposed to laser light at a wavelength of 785 nanometers, a strong Raman signal is given off that can be detected with a special Raman microscope. Exposure to laser light at 808 nanometers (near infrared or NIR) causes the SWNTs to heat up, which results in thermal destruction of living tissue in the near vicinity.

Investigators at the [U.S.] National Institute of Standards and Technology (Gaithersburg, MD, USA) worked with two types of cancer cells growing in tissue culture. Both HER2-expressing SK-BR-3 cells and HER2-negative MCF-7 cells were treated with the IgY-SWNTs and then exposed to different wavelengths of laser light.

Results published in the October 2, 2009, issue of the journal BMC Cancer revealed that the anti-HER2 IgY guided the nanotubes to those cells expressing HER2. Thus, the Raman signal collected at single-cell level from the SWNT-treated SK-BR-3 cells was significantly greater than that from the MCF-7 cells. Exposure to NIR irradiation selectively destroyed the SWNT-targeted breast cancer cells without harming receptor-free cells. Significantly, cell death was effectuated without the need of internalization of SWNTs by the cancer cells.

The authors concluded that, "The complex can be potentially used for both detection and selective photothermal ablation of receptor-positive breast cancer cells without the need of internalization by the cells. Thus, the unique intrinsic properties of SWNTs combined with high specificity and sensitivity of IgY antibodies can lead to new strategies for cancer detection and therapy."

Related Links:
[U.S.] National Institute of Standards and Technology


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.